Retail Trade MatsukiyoCocokara & Co. Business Summary
MatsukiyoCocokara & Co. engages in the management and supervision of its group companies that are in drugstore and pharmacy operations. It operates through the following segments: Retail Business, Wholesale Business, and Management Support. The Retail Business segment deals with the retail sales of pharmaceutical and related products. The Wholesale Business segment operates as a wholesale distributor of medicines and miscellaneous daily goods, and offers franchising services. The Management Support segment manages the Group and indirect operations. The company was founded on October 1, 2007 and is headquartered in Matsudo, Japan.
Financial Highlights
Mar 2022
JPY USD Revenue 729,969M 6,495.96M Gross Profit 225,434M 2,006.12M Operating income 41,849M 372.41M Income before tax 49,629M 441.64M Net income 34,589M 307.80M EBITDA 56,710M 504.66M Diluted EPS 283.05 2.51 Dividends Per Share 75 0.66 Total Assets 656,735M 5,410.79M Total liabilities 192,389M 1,585.07M Total equity 464,317M 3,825.47M Operating cash flow 39,812M 354.28M Currency in JPY Currency in USD
Historical Data Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
558,879M
575,991M
590,593M
544,737M
729,969M
Gross Profit
161,502M
171,249M
181,036M
162,663M
225,434M
Operating income
33,567M
36,029M
37,554M
31,820M
41,849M
Income before tax
34,418M
37,369M
39,078M
32,666M
49,629M
Net income
22,755M
25,035M
26,176M
21,602M
34,589M
EBITDA
41,271M
44,262M
45,957M
40,398M
56,710M
Diluted EPS
214.92
239.32
254.93
210.36
283.05
Dividends Per Share
55
65
70
70
75
Total Assets
314,178M
318,324M
351,809M
368,936M
656,735M
Total liabilities
109,303M
109,050M
122,499M
122,711M
192,389M
Total equity
204,871M
209,269M
229,304M
246,220M
464,317M
Operating cash flow
27,938M
21,897M
24,764M
25,875M
39,812M
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
5,042.55M
5,194.03M
5,431.95M
5,136.24M
6,495.96M
Gross Profit
1,457.17M
1,544.24M
1,665.06M
1,533.72M
2,006.12M
Operating income
302.86M
324.89M
345.40M
300.02M
372.41M
Income before tax
310.54M
336.97M
359.41M
308.00M
441.64M
Net income
205.30M
225.75M
240.75M
203.68M
307.80M
EBITDA
372.37M
399.13M
422.68M
380.90M
504.66M
Diluted EPS
1.93
2.15
2.34
1.98
2.51
Dividends Per Share
0.49
0.58
0.64
0.66
0.66
Total Assets
2,954.18M
2,875.94M
3,258.84M
3,338.78M
5,410.79M
Total liabilities
1,027.76M
985.22M
1,134.72M
1,110.50M
1,585.07M
Total equity
1,926.38M
1,890.67M
2,124.07M
2,228.23M
3,825.47M
Operating cash flow
252.07M
197.45M
227.76M
243.97M
354.28M
Valuation Measures
Mar 2022
PER 15.31 ROA 6.74% ROE 9.73% Operating margin 5.73% Profit margin 4.73%
Key executives
President & Representative Director:
Kiyoo Matsumoto
Manager-Finance & Accounting:
Hiroshi Nishida
Senior Manager-Information System:
Hidesato Hiramatsu
Representative Director & Vice President:
Atsushi Tsukamoto
Executive Officer & Head-Kyushu Sales:
Takao Watanabe Shareholders
MATSUMOTO NAMIO (5.0%)
The Chiba Bank, Ltd. (3.5%)
Nomura Asset Management Co., Ltd. (3.2%)
Columbia Management Investment Advisers LLC (2.4%)
The Vanguard Group, Inc. (2.1%)
Eisai Co., Ltd. (1.9%)
MATSUMOTO KIYOO (1.7%)
MATSUMOTO TAKASHI /MATSUMOTOKIYOSHI/ (1.7%)
MatsukiyoCocokara & Co. (1.6%)
Matsukiyococokara Employee Stock Ownership Plan (1.5%)
Related Companies
Matsukiyococokara Restricted Stock Compensation Plan
Matsukiyococokara Employee Stock Ownership Plan
Matsumotokiyoshi Insurance Service Co., Ltd.
Matsumotokiyoshi Wholesale Co., Ltd.
Matsumotokiyoshi Pharmacies Co., Ltd.
Matsumotokiyoshi Kyushu Sales Co., Ltd.
Matsumotokiyoshi Hd Restricted Stock Compensation Plan
Matsumotokiyoshi Holdings Employee Incentive Plan
Matsumotokiyoshi Holdings Board Incentive Plan
Daruma Drug Co., Ltd.
Matsumotokiyoshi Kou-Shin-Etsu Japan Co., Ltd.
Yukari Kokoku KK
MK Higashinihon Hambai KK
Tobu Drug KK
MK Planning KK
Moris Retail KK
Koyo Yakuhin Co., Ltd.
Sugiura Co., Ltd.
Itayama Medico Co. Ltd.
Nakajima Family Yakkyoku KK
Shimeno Yakkyoku KK
Matsumotokiyoshi Asset Management Co., Ltd.
Love Drugs Co., Ltd.
Matsumotokiyoshi Co., Ltd.
Midoriyakuhin Co., Ltd.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Last Updated on 3 Feb, 2023
Take your reading anywhere with offline reading functions Never miss a story with breaking news alerts Customize your reading experience
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close
